Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01286454 · ClinicalTrials.gov registry record · Phase 1
This Is A Study Of Bioavailability And Food Effect For Fesoterodine.
A Phase 1 study of Overactive Bladder (OAB) With Symptoms of Frequency, Urgency, and Urgency, sponsored by Pfizer.
- Completed
- Registry status
- Phase 1
- Development phase
- 20
- Enrollment target
- 1
- Study location
NCT01286454: Completed Phase 1 study of Overactive Bladder (OAB) With Symptoms of Frequency, Urgency, and Urgency, sponsored by Pfizer.
NCT01286454 is a Phase 1 study of Overactive Bladder (OAB) With Symptoms of Frequency, Urgency, and Urgency that has completed, run by Pfizer. The registered enrollment target is 20 participants, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (67% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01286454, a Phase 1 study of Overactive Bladder (OAB) With Symptoms of Frequency, Urgency, and Urgency, has completed, sponsored by Pfizer.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 20 participants
- Enrollment target
- 1
- Study location
Study Summary
This Is A Study Of Bioavailability And Food Effect For Fesoterodine.
Primary Outcome
AUC (0 - ∞) = Area under the plasma concentration versus time curve (AUC) from time zero to extrapolated infinite time (0 - ∞). It is obtained from AUC (0 - t) plus AUC (t - ∞).
Conditions Studied
Interventions
- DRUG fesoterodine
Study Locations (1)
Connecticut
- Pfizer Investigational Site - New Haven
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2010-12 |
| Est. Completion | 2011-03 |
| Phase | Phase 1 |
What the finished NCT01286454 record still lists
NCT01286454 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 60-participant average among 29,502 other Phase 1 trials with a reported enrollment target (67% lower).
The record links to 1 condition, with Overactive Bladder (OAB) With Symptoms of Frequency, Urgency, and Urgency appearing as the primary indexed condition, and to 1 intervention - of which fesoterodine is the first listed.
NCT01286454 reports a single indexed study location in Connecticut.
Frequently Asked Questions
What is clinical trial NCT01286454 about?
NCT01286454 is a clinical study titled "This Is A Study Of Bioavailability And Food Effect For Fesoterodine.". This Is A Study Of Bioavailability And Food Effect For Fesoterodine.
What is the current status of trial NCT01286454?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 20 participants. The study started on 2010-12. Estimated completion is 2011-03.
What conditions does trial NCT01286454 study?
This clinical trial studies the following conditions: Overactive Bladder (OAB) With Symptoms of Frequency, Urgency, and Urgency.
What interventions are being tested in trial NCT01286454?
The interventions under investigation include: fesoterodine (DRUG).
Who is sponsoring clinical trial NCT01286454?
This trial is sponsored by Pfizer, which has 1,845 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01286454 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01286454's enrollment target sits among peer trials
20 1629th of 2000 higher than 285 of 2,000 other Phase 1 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 1 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia